Operating Margin of Akebia Therapeutics, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Akebia Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Akebia Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2025 was 10%.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2025 was 10%.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2024 was -32%, a 33% decline from 2023.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2023 was -24%, a 14% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Akebia Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 10% +41% 01 Oct 2025 31 Dec 2025
Q3 2025 7.9% +28% 01 Jul 2025 30 Sep 2025
Q2 2025 0.39% +21% 01 Apr 2025 30 Jun 2025
Q1 2025 -12% +7.1% +37% 01 Jan 2025 31 Mar 2025
Q4 2024 -32% -7.7% -33% 01 Oct 2024 31 Dec 2024
Q3 2024 -20% +6.6% +24% 01 Jul 2024 30 Sep 2024
Q2 2024 -20% +25% +55% 01 Apr 2024 30 Jun 2024
Q1 2024 -19% -1.7% -10% 01 Jan 2024 31 Mar 2024
Q4 2023 -24% +3.8% +14% 01 Oct 2023 31 Dec 2023
Q3 2023 -27% +21% +44% 01 Jul 2023 30 Sep 2023
Q2 2023 -45% +4.7% +9.6% 01 Apr 2023 30 Jun 2023
Q1 2023 -17% +100% +85% 01 Jan 2023 31 Mar 2023
Q4 2022 -28% +97% +78% 01 Oct 2022 31 Dec 2022
Q3 2022 -48% +88% +65% 01 Jul 2022 30 Sep 2022
Q2 2022 -49% +81% +62% 01 Apr 2022 30 Jun 2022
Q1 2022 -117% +31% +21% 01 Jan 2022 31 Mar 2022
Q4 2021 -125% +2.8% +2.2% 01 Oct 2021 31 Dec 2021
Q3 2021 -136% -10% -8.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -130% -17% -15% 01 Apr 2021 30 Jun 2021
Q1 2021 -148% -71% -93% 01 Jan 2021 31 Mar 2021
Q4 2020 -128% -42% -50% 01 Oct 2020 31 Dec 2020
Q3 2020 -125% -39% -45% 01 Jul 2020 30 Sep 2020
Q2 2020 -113% -24% -27% 01 Apr 2020 30 Jun 2020
Q1 2020 -77% +21% +22% 01 Jan 2020 31 Mar 2020
Q4 2019 -85% +0.3% +0.35% 01 Oct 2019 31 Dec 2019
Q3 2019 -87% 01 Jul 2019 30 Sep 2019
Q2 2019 -88% 01 Apr 2019 30 Jun 2019
Q1 2019 -98% 01 Jan 2019 31 Mar 2019
Q4 2018 -86% 01 Oct 2018 31 Dec 2018

Akebia Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 10% +41% 01 Jan 2025 31 Dec 2025
2024 -32% -7.7% -33% 01 Jan 2024 31 Dec 2024
2023 -24% +3.8% +14% 01 Jan 2023 31 Dec 2023
2022 -28% +97% +78% 01 Jan 2022 31 Dec 2022
2021 -125% +3.3% +2.5% 01 Jan 2021 31 Dec 2021
2020 -128% -43% -50% 01 Jan 2020 31 Dec 2020
2019 -85% +0.3% +0.35% 01 Jan 2019 31 Dec 2019
2018 -86% -43% -103% 01 Jan 2018 31 Dec 2018
2017 -42% +8848% +100% 01 Jan 2017 31 Dec 2017
2016 -8890% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.